Error: Could not add to watchlist. X

AXA Framlington Health Fund

+ Watchlist
FRAHEAA:LN
1,641.00
GBp
17.00
1.05%
As of 00:59:30 ET on 07/01/2015.
Volume
0
Previous Close
1,624.00
52Wk Range
1,193.78 - 1,736.00
1 Yr Return
34.42%
Fund Type
-
Objective
-
Asset Class Focus
-
Geographic Focus
-
NAV (on 07/01/2015)
1,641
Total Assets (m GBp) (on 01/30/2015)
511.600
Inception Date
04/03/1987
Last Dividend (on 05/01/2015)
-
Dividend Indicated Gross Yield
-
Fund Managers
MARK HARGRAVES / LINDEN THOMSON
Front Load Fee
5.50%
Back Load Fee
0.00%
Redemption Fee
0.00%
12b-1 Fee
-
Current Mgmt Fee
1.50%
Expense Ratio
-
Top Fund Holdings
Name Position Value % of Fund
Roche Holding AG 162.97 k 31.29 m 5.60
Gilead Sciences Inc 396.60 k 29.05 m 5.20
Novartis AG 366.50 k 24.58 m 4.40
Amgen Inc 207.48 k 21.23 m 3.80
AbbVie Inc 474.07 k 20.67 m 3.70
Biogen Inc 70.92 k 18.44 m 3.30
Celgene Corp 216.21 k 16.20 m 2.90
Allergan plc 80.64 k 16.20 m 2.90
Medtronic PLC 290.66 k 14.53 m 2.60
UnitedHealth Group Inc 178.19 k 13.97 m 2.50
Profile
AXA Framlington Health Fund is an authorized unit trust incorporated in the United Kingdom. The aim of the Fund is to achieve capital growth. It invests in producers of pharmaceuticals, bio-technology firms, medical device and instrument manufacturers, distributors of healthcare products, care providers and managers and other healthcare services companies along ethical guidelines.
ADDRESS
AXA Framlington Unit Management Ltd
7 Newgate Street
London EC1A 7NX
United Kingdom
PHONE
44-207-374-4100